Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliable change indices for 16 neuropsychological tests at six different time points.

Neurologia·2025
Same author

Long-term brain structural and cognitive outcomes in a low-risk preterm-born sample.

Scientific reports·2024
Same author

Amygdala structure and function and its associations with social-emotional outcomes in a low-risk preterm sample.

Brain structure & function·2024
Same author

UD Interference Test: creation and validation of a new instrument of resistance to interference. Normalisation and standardisation for Spanish population.

Neurologia·2023
Same author

Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

Multiple sclerosis and related disorders·2023
Same author

[Translated article] Design and comparison of bone substitutes. Study of in vivo behaviour in a rabbit model.

Revista espanola de cirugia ortopedica y traumatologia·2023
Same journal

Design and Process Parameter Evaluation of Bilayer Capsule Systems for Targeted Ileal Drug Delivery.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

iRGD-Modified Peptide-Drug Conjugate Improves Brain Delivery and Antitumor Efficacy in Glioblastoma.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

A Δ‑Based Framework For Internal Release Limits In Plateau Stability Systems.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

Innovative Peptide Formulations for Cardiovascular Diseases Using Supercritical CO<sub>2</sub>: A Comprehensive Review and Potential Applications.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

Lipid nanoparticles for Cas9 ribonucleoprotein delivery: design and evaluation of ionisable oligoamine-lipidoids.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Tailoring vancomycin release from beta-TCP/agarose scaffolds.

M V Cabañas1, J Peña, J Román

  • 1Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|June 4, 2009
PubMed
Summary
This summary is machine-generated.

Researchers developed novel beta-tricalcium phosphate (beta-TCP)/agarose scaffolds for controlled vancomycin release. Formulation and drying methods were optimized to tailor drug elution for enhanced performance.

More Related Videos

Monitoring GPCR-&#946;-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

Related Experiment Videos

Last Updated: Jun 22, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Monitoring GPCR-&#946;-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Tissue Engineering

Background:

  • Controlled drug release is crucial for effective therapeutic outcomes.
  • Scaffold fabrication methods significantly influence drug elution profiles.
  • Beta-tricalcium phosphate (beta-TCP) and agarose are promising biomaterials for regenerative medicine.

Purpose of the Study:

  • To fabricate beta-tricalcium phosphate (beta-TCP)/agarose scaffolds.
  • To tailor vancomycin release by incorporating poly(ethylene glycol) (PEG) and optimizing drying techniques.
  • To investigate the impact of fabrication and preservation methods on scaffold performance and drug release.

Main Methods:

  • Scaffold fabrication using a low-temperature shaping technique.
  • Incorporation of vancomycin and poly(ethylene glycol) (PEG).
  • Application of freeze-drying and heat desiccation (37°C) for scaffold preservation.

Main Results:

  • Successful fabrication of beta-TCP/agarose scaffolds capable of controlled vancomycin release.
  • Different pore architectures and chemical interactions (e.g., agarose-PEG-vancomycin complex) were observed based on drying methods.
  • Distinct vancomycin release patterns were achieved through tailored fabrication and preservation.

Conclusions:

  • Multifaceted approach to scaffold fabrication enhances control over drug release.
  • Drying techniques (freeze-drying vs. heat desiccation) critically influence scaffold properties and drug elution.
  • Developed scaffolds exhibit hydrogel-like behavior in hydrated media and bone-like consistency, indicating potential for biomedical applications.